Overview

Update
Status
Aarden Pharmaceuticals has been closed
Total Equity Funding
$500k in 1 Round from 1 Investor
Headquarters:
Indianapolis, Indiana
Description:
Aarden Pharmaceuticals develops drugs targeting protein tyrosine phosphatases that catalyze the removal of phosphate groups.
Founders:
, ,
Categories:
Pharmaceutical, Biotechnology
Website:
http://aardenpharma.com
Social:

Company Details

Update

Aarden Pharmaceuticals is a small molecule drug discovery and development company. The company’s novel technology is a chemistry breakthrough that will enable it to make drugs against a previously un-druggable set of intracellular phosphatase (PTP) disease targets. The technology was developed in the laboratory of Dr. Zhong-Yin Zhang, Robert A. Harris Professor and chairman of biochemistry and molecular biology at the Indiana University School of Medicine. Zhang is an internationally recognized expert in the field of protein tyrosine phosphatases (PTPs). Aarden’s first programs are focused on infectious disease, cancer, and metabolic and autoimmune conditions.

Funding Rounds (1) - $500k

Update
DateAmount / RoundValuationLead InvestorInvestors
Jan, 2011$500k / Seed1

Investors (1)

InvestorRound(s)Partner(s)
Seed-

News (1)

Update
DateNews
Nov 27, 2013SEC - SEC FORM D/A

Offices/Locations (1)

Update
  • Office

    351 West 10th Street

    Suite 248

    Indianapolis, Indiana 46202

    United States

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos